Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
Benzinga
APRIL 17, 2024
On Wednesday, Vanda Pharmaceuticals Inc. NASDAQ: VNDA ) confirmed that, since March 2024, it had received several unsolicited proposals from Future Pak LLC to acquire all of Vanda’s outstanding shares. to Vanda’s closing price of $4.05 to Vanda’s closing price of $4.05 as of April 16, 2024.
Let's personalize your content